A new report released by Unleash Prosperity, a free-market policy group, estimates that curing cancer could deliver an unprecedented $185 trillion economic windfall to the U.S. economy over the next 35 years [1]. The research, conducted by economists Steve Moore and Tomas Philipson, projects that fully eliminating cancer mortality would not only save millions of lives but also dramatically strengthen the economy through longer lifespans, increased workforce participation, and higher tax revenues [1]. Specifically, the report calculates that this would translate to roughly $15,000 per American per year, or about $39,000 annually for the average household [1].
The stakes are significant, as between 2030 and 2064, approximately 30.7 million Americans are expected to die from cancer under current trends, resulting in both a profound human toll and sweeping economic costs [1]. Even if cancer deaths are reduced by 80% over 20 years, the projected gains for the economy would still total nearly $130 trillion, which is about 70% of the value of full elimination and amounts to roughly $10,500 per person per year [1].
Economist Steve Moore emphasized that reducing cancer deaths could boost productivity enough to meaningfully accelerate U.S. economic growth. He stated, "If we could substantially reduce cancer deaths, the payoff would be as large as just about anything you can imagine," and suggested that the current economic growth rate of about 3% could potentially increase by a full percentage point, which would have enormous implications for national debt and deficit [1]. Moore further argued that this should be a top national priority, as it would increase both Americans’ health and wealth [1].
The report also notes that as researchers continue to develop new therapies and early detection tools, the focus should shift from whether progress is possible to how quickly it can be accelerated [1].
CONCLUSION
The report underscores the immense economic and societal benefits of curing or substantially reducing cancer mortality, projecting trillions in gains and a significant boost to U.S. economic growth. Even partial progress could yield substantial returns, making cancer research a high-priority investment for policymakers. The findings suggest that accelerating advancements in cancer treatment could have transformative effects on both health and wealth in the United States.